Literature DB >> 27392541

Overweight, obesity and the risk of gallbladder and extrahepatic bile duct cancers: A meta-analysis of observational studies.

Liqing Li1,2, Yong Gan2, Wenzheng Li2, Chunmei Wu2, Zuxun Lu2.   

Abstract

OBJECTIVE: Epidemiological studies have repeatedly investigated the association between excess body weight and the risk of biliary tract cancer with inconsistent results. The objective of this study was to quantitatively assess the associations between overweight and obesity and the risk of biliary tract cancer.
METHODS: A comprehensive search of PubMed, Embase, Web of Science, and China National Knowledge Infrastructure databases up to August 2015 was conducted, and the reference lists of retrieved articles for additional relevant studies were manually searched.
RESULTS: Fourteen prospective cohort studies and 15 case-control studies were included in this meta-analysis. These studies included 11,448,397 participants (6,733 patients with gallbladder cancer [GBC] and 5,798 patients with extrahepatic bile duct cancer [EBDC]) with follow-up durations ranging from 5 to 23 years. Among overweight adults, the pooled RR was 1.17 (95% CI, 1.07-1.28) for GBC and 1.26 (95% CI, 1.14-1.39) for EBDC, and among people with obesity, the pooled RR was 1.62 (95% CI, 1.49-1.75) for GBC and 1.48 (95% CI, 1.21-1.81) for EBDC. Visual inspection of the funnel plots and the Begg's and the Egger's tests did not show enough evidence of publication bias.
CONCLUSIONS: Integrated evidence from this meta-analysis suggests that excess body weight is associated with a significantly increased risk of GBC and EBDC.
© 2016 The Obesity Society.

Entities:  

Mesh:

Year:  2016        PMID: 27392541     DOI: 10.1002/oby.21505

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  8 in total

1.  Cancers Due to Excess Weight, Low Physical Activity, and Unhealthy Diet.

Authors:  Gundula Behrens; Thomas Gredner; Christian Stock; Michael F Leitzmann; Hermann Brenner; Ute Mons
Journal:  Dtsch Arztebl Int       Date:  2018-09-03       Impact factor: 5.594

Review 2.  The Science of Obesity Management: An Endocrine Society Scientific Statement.

Authors:  George A Bray; William E Heisel; Ashkan Afshin; Michael D Jensen; William H Dietz; Michael Long; Robert F Kushner; Stephen R Daniels; Thomas A Wadden; Adam G Tsai; Frank B Hu; John M Jakicic; Donna H Ryan; Bruce M Wolfe; Thomas H Inge
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

Review 3.  Insulin and cancer: a tangled web.

Authors:  Brooks P Leitner; Stephan Siebel; Ngozi D Akingbesote; Xinyi Zhang; Rachel J Perry
Journal:  Biochem J       Date:  2022-03-18       Impact factor: 3.766

4.  Overweight and Obesity among Sexual Minority Adults in the United States.

Authors:  Sunday Azagba; Lingpeng Shan; Keely Latham
Journal:  Int J Environ Res Public Health       Date:  2019-05-23       Impact factor: 3.390

Review 5.  Targeting Chronic Inflammation of the Digestive System in Cancer Prevention: Modulators of the Bioactive Sphingolipid Sphingosine-1-Phosphate Pathway.

Authors:  Eileen M McGowan; Yiguang Lin; Size Chen
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

Review 6.  The role of diet and nutrition related indicators in biliary diseases: an umbrella review of systematic review and meta-analysis.

Authors:  Yaoqun Wang; Jiong Lu; Ningyuan Wen; Guilin Nie; Dingzhong Peng; Xianze Xiong; Nansheng Cheng; Bei Li
Journal:  Nutr Metab (Lond)       Date:  2022-07-30       Impact factor: 4.654

7.  Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer.

Authors:  Shuai Huang; Hui Wang; Wei Chen; Ming Zhan; Sunwang Xu; Xince Huang; Ruirong Lin; Hui Shen; Jian Wang
Journal:  J Cell Mol Med       Date:  2019-11-28       Impact factor: 5.310

Review 8.  Microbiota's role in health and diseases.

Authors:  Amr El-Sayed; Mohamed Kamel; Lotfi Aleya
Journal:  Environ Sci Pollut Res Int       Date:  2021-05-27       Impact factor: 5.190

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.